Filter Results:
(1,253)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 01 Mar 2014
- News
My HBS Eureka Moment
uncomfortable with the ethnic background of the proponents, who were proposing to start a pharmaceutical company in Mexico. I could never get comfortable, and missed a huge opportunity. The product was the birth control pill." The lesson... View Details
- 01 Feb 2001
- News
Drilling Down
Exchange. "The role of intellectual capital is more important in this business than any other, except perhaps the pharmaceutical and computer science industries. Oil is a hugely volatile commodity that very few people want to play in, so... View Details
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details
Keywords: Ethics; Policy; Government and Politics; Health Pandemics; History; Rights; Media; Organizations; Business and Community Relations; Religion; Social Psychology; Identity; Prejudice and Bias; Social Issues; Public Opinion; Pharmaceutical Industry; Biotechnology Industry; Health Industry; Journalism and News Industry; Media and Broadcasting Industry; Public Administration Industry; United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
case:https://hbsp.harvard.edu/product/118054-PDF-ENG Harvard Business School Case 318-108 Hikma Pharmaceuticals Governance Journey The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics... View Details
Keywords: Dina Gerdeman
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to... View Details
Keywords: Sean Silverthorne
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech View Details
Keywords: Sean Silverthorne
- 05 May 2023
- News
Fail Better
Organization before being recruited to Boston-based Vertex Pharmaceuticals in 2017, where she was named CEO and president in 2020. Confessing her own discomfort with failure, Kewalramani reflects on an experience earlier in her career... View Details
- 01 Apr 2000
- News
Getting the Message
Sponsorships allow advertisers to offer content that is related to their products or services and valued by the target audience. For example, a pharmaceutical company might sponsor a bulletin board for consumers with a specific ailment.... View Details
Keywords: Susan Young
- Research Summary
Overview
By: Andy Wu
How can technology entrepreneurs build competitive advantage from the ground up? Professor Andy Wu conducts scholarly research and develops course materials that document how technology entrepreneurs can (1) organize for innovation to create new market opportunities... View Details
Keywords: Strategy; Entrepreneurship; Venture Capital; Growth Management; Organizational Design; Organizational Structure; Technology Platform; Technological Innovation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; China; Southeast Asia; South Asia
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped... View Details
Keywords: Martha Lagace
- 26 Jul 2010
- Research & Ideas
Yes, You Can Raise Prices in a Downturn
have told the Wright brothers, "Don't do it: it's a bad use of capital!" Yet over the past two decades, Ryanair's ROE was often comparable to the best returns in the pharmaceutical business—a traditional example of a... View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
going to take care of themselves, meaning prescriber limits are coming down, the way that doctors are prescribing is changing, CDC have got guidelines, lawsuits against these pharmaceutical companies and the distributors. All those things... View Details
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
opposed. Which path should ZappRx take? The case is a window into the early go-to-market and business model decisions that an entrepreneur must make, in this case in the face of pushback from her own management team. The case also provides a detailed picture of the... View Details
Keywords: Sean Silverthorne
- 12 Jan 2010
- First Look
First Look: Jan. 12
and illustrates, via a detailed description of the successful strategic alliance between Solvay Pharmaceuticals Inc. and Quintiles company how the creation of a strategy map and Balanced Scorecard helps align the separate interests of... View Details
Keywords: Martha Lagace
- 19 Aug 2024
- News
Quantum Leap
with one another, making it far easier to do everything from discovering new medicines to designing better batteries. The pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for... View Details
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
- 21 May 2013
- First Look
First Look: May 21
pharmaceutical sales teams in Belgium and sports teams in Canada. These results suggest that a minor adjustment to employee bonuses-shifting the focus from the self to others-can produce measurable benefits for employees and... View Details
Keywords: Sean Silverthorne
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially... View Details
Keywords: Carmen Nobel
- 05 Aug 2008
- First Look
First Look: August 5, 2008
/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver... View Details
Keywords: Martha Lagace